DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)
China
· Delayed Price · Currency is CNY 14.40
-0.24 (-1.64%)
Jan 3, 2025, 3:00 PM CST
DaShenLin Pharmaceutical Group Revenue
DaShenLin Pharmaceutical Group had revenue of 6.39B CNY in the quarter ending September 30, 2024, with 11.42% growth. This brings the company's revenue in the last twelve months to 26.54B, up 9.88% year-over-year. In the year 2023, DaShenLin Pharmaceutical Group had annual revenue of 24.53B with 15.45% growth.
Revenue (ttm)
26.54B
Revenue Growth
+9.88%
P/S Ratio
0.62
Revenue / Employee
583.72K
Employees
45,466
Market Cap
16.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 24.53B | 3.28B | 15.45% |
| Dec 31, 2022 | 21.25B | 4.49B | 26.78% |
| Dec 31, 2021 | 16.76B | 2.18B | 14.92% |
| Dec 31, 2020 | 14.58B | 3.44B | 30.89% |
| Dec 31, 2019 | 11.14B | 2.28B | 25.76% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |